NCCN Guidelines for Patients
: Chronic Myelogenous Leukemia
1.1 What are blood cells?
3 5 Tools
American Cancer Society
Leukemia and Lymphoma Society
National Cancer Institute
National Marrow Donor Program
• CML is divided into three groups (phases) of progression.
• The phase of CML is based on the number of immature white blood cells, called blasts, in
the peripheral blood and bone marrow.
• Prognostic scoring systems use certain factors to help predict the likely outcome
(prognosis) and guide treatment decisions.
Review of Part 3